# Extending Ketamine's Effects in OCD With Exposure and Response Prevention (EX/RP)

> **NCT02062658** · PHASE2 · COMPLETED · sponsor: **New York State Psychiatric Institute** · enrollment: 10 (actual)

## Conditions studied

- Obsessive-Compulsive Disorder

## Interventions

- **DRUG:** Ketamine
- **BEHAVIORAL:** Exposure and Response Prevention

## Key facts

- **NCT ID:** NCT02062658
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2016-12-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02062658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02062658, "Extending Ketamine's Effects in OCD With Exposure and Response Prevention (EX/RP)". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT02062658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*